|  Help  |  About  |  Contact Us

Publication : Arylsulfatase I is a novel lysosomal chondroitin endosulfatase regulating endochondral ossification.

First Author  Grecco-Machado R Year  2026
Journal  Matrix Biol Volume  145
Pages  75-88 PubMed ID  41916471
Mgi Jnum  J:382983 Mgi Id  MGI:8321230
Doi  10.1016/j.matbio.2026.03.005 Citation  Grecco-Machado R, et al. (2026) Arylsulfatase I is a novel lysosomal chondroitin endosulfatase regulating endochondral ossification. Matrix Biol
abstractText  During endochondral ossification, chondrocytes undergo maturation and biochemically modify the collagenous extracellular matrix of cartilage. Similar modifications to cartilage proteoglycans (PGs), which are predominantly chondroitin sulfate PGs, have not been characterized. Using synchrotron X-ray fluorescence imaging, we demonstrated that PG sulfation significantly decreased during cartilage maturation of chick embryos. Laser-capture microdissection and RNAseq revealed upregulation of Arylsulfatase I (Arsi) in mature cartilage of mouse. ARSI protein also increased in mature cartilage of mouse and chick in vivo and during maturation of ATDC5 chondrocytes in vitro, whereas expression of the two known chondroitin sulfate PG sulfatases (ARSB and GALNS) was not specific to mature cartilage. Colocalization studies suggested that ARSI is lysosomal, and lysosome homeostasis was altered in ARSI loss of function chondrocytes. Biochemical analyses of ARSI gain and loss of function cell lines and isolated cell-free systems revealed that ARSI is a novel chondroitin endosulfatase, specifically desulfating chondroitin-4-sulfate at pH 4.5. Finally, Arsi knockout in RCS chondrocytes caused increased expression of maturation genes, such as Col10a1 and Mmp13. In total, these data identify ARSI as a novel PG sulfatase regulating endochondral ossification.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

0 Expression